How MDR notified bodies are designated and how to choose one
Under Regulation (EU) 2017/745, every class IIa, IIb and III medical device, plus class I devices that are sterile, have a measuring function or are reusable surgical instruments, needs a notified body before the CE mark can be affixed. Notified bodies are private or public conformity assessment bodies that a national authority has designated after a joint assessment with the European Commission and auditors from other Member States. Each one carries a permanent four-digit identification number that appears next to the CE mark on certified devices and on every MDR certificate.
Why the pool is small
The MDR made designation far harder than under the old Medical Device Directive (93/42/EEC). Bodies had to reapply from scratch, demonstrate in-house clinical and technical expertise for every code they wanted, and pass an on-site joint assessment. Several dozen bodies that held MDD notifications never obtained an MDR designation, so the number of MDR bodies has grown slowly since the first designation in early 2019 and remains around fifty. Capacity, not price, is often the binding constraint: many bodies have waiting times for new applications, and some only accept manufacturers whose devices fit narrow technology niches.
Reading a designation scope
A designation does not cover every device. The scope is expressed in codes defined in Commission Implementing Regulation (EU) 2017/2185:
- MDA / MDN codes describe the device type, split into active (MDA) and non-active (MDN) devices.
- MDS codes cover horizontal characteristics such as devices incorporating medicinal substances, sterile devices or devices utilising nanomaterials.
- MDT codes cover manufacturing technologies such as metal processing, plastic processing or electronic component assembly.
A body can only certify a device if it holds the matching MDA/MDN code and every applicable MDS and MDT code. A body may also be limited to particular conformity assessment annexes, for example Annex IX (quality management system and technical documentation assessment) but not Annex X (type examination).
What regulatory teams compare
| Criterion | Why it matters |
|---|---|
| Scope codes | Determines whether the body can legally certify the device at all |
| Designating country | Sets the supervising competent authority, audit languages and working culture |
| IVDR co-designation | Useful for companion diagnostics and combined portfolios under Regulation (EU) 2017/746 |
| Specialisation | Some bodies focus on software and AI, others on implants or high-volume consumables |
| Group structure | Large testing and certification groups may also offer ISO 13485, MDSAP or UKCA services |
Where the official record sits
The authoritative record of each designation is the NANDO information system run by the European Commission, now part of the Single Market Compliance Space. Each body's entry links to a scope document listing its codes and annexes. Because scopes are extended or restricted over time, a shortlist should always be checked against the current NANDO scope document before an application is signed. Countries outside the EU, such as Norway (EEA) and Türkiye (customs union arrangements), also designate MDR bodies, while Switzerland and the United Kingdom no longer do.
Practical tips for selection
- Map every device in the portfolio to its MDA/MDN, MDS and MDT codes before contacting bodies.
- Ask for the body's current lead time for technical documentation review, not only for the QMS audit.
- Check whether clinical evaluation consultation procedures (Article 54) or expert panels will be involved for class III implantables.
- Confirm the language of the technical documentation the body accepts.
- For transfers from another notified body, review the transitional rules in Regulation (EU) 2023/607 and the written agreement required between the old and new body.